SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
Immune Checkpoint Blockade Targeting the Novel PSGL-1/VISTA Axis for Pancreatic Cancer
Immune Checkpoint Blockade Targeting the Novel PSGL-1/VISTA Axis for Pancreatic Cancer is a funding opportunity from SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE, up to 209674, closing February 28, 2027.
Feb 28, 2027
(212d left)Overview
Project Summary The goal of this project is to develop a novel immunotherapy to treat PDAC based on blockade of PSGL-1 (P- selectin glycoprotein ligand-1), to identify the attendant cellular and transcriptional changes in tumors comprising high vs low T cell infiltration, and to determine whether resistance to current…